SCHEMBL8206609

SCHEMBL8206609

CCC[C@H](NOC)C(=O)NCCc1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
RAB9A P51151 4/20 0.52
HTT P42858 2/20 0.51
ATM Q13315 1/20 0.51
NPY1R P25929 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
NPC1 O15118 2/20 0.47
TAS1R3 Q7RTX0 2/20 0.47
TAS1R1 Q7RTX1 2/20 0.47
TSHR P16473 1/20 0.46
TLR2 O60603 1/20 0.45
LMNA P02545 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HRH3 Q9Y5N1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8208537 0.83 KMT2A (0.53) KMT2ARAB9AHTTATMNPY1R
SCHEMBL8202246 0.78 KMT2A (0.50) KMT2ARAB9AHTTATMNPY1R
SCHEMBL15579555 0.77 KMT2A (0.48) KMT2ARAB9AHTTATMNPY1R
SCHEMBL10311684 0.77 HTT (0.64) KMT2ARAB9AHTTATMSMN1; SMN2
SCHEMBL8918338 0.77 KMT2A (0.52) KMT2ARAB9AHTTATMNPY1R
SCHEMBL8285006 0.76 RAB9A (0.57) RAB9AHTTATMSMN1; SMN2ALDH1A1
SCHEMBL8204200 0.75 CAPN1 (0.53) KMT2AHTTATMNPY1RSMN1; SMN2
SCHEMBL8196260 0.75 CAPN1 (0.53) KMT2AHTTATMNPY1RSMN1; SMN2
SCHEMBL14123209 0.75 CAPN1 (0.53) KMT2AHTTATMNPY1RSMN1; SMN2
SCHEMBL10558453 0.75 HTT (0.62) KMT2ARAB9AHTTATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008042480-A2 EPOXIDE INHIBITORS OF CYSTEINE PROTEASES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2008-04-10 WO disclosed